Overview
- 97 inspections across 92 sites are on record.
- 299 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-22.
At a glance
Inspections
97
Sites
92
Observations
299
Career since
Dec 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Shanghai Ambiopharm Inc. | 22 May 2026 | Human Drugs | On file |
| Henan Enokon Medical Instrument Co., Ltd. | 23 Jan 2026 | Human Drugs | On file |
| Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) | 15 Dec 2025 | Human Drugs | On file |
| Blue Sea Aerosol & Daily Care Co., Ltd | 31 Oct 2025 | Human Drugs | On file |
| Zhejiang Lepu Pharmaceutical Co., Ltd. | 25 Apr 2025 | Human Drugs | On file |
Sites inspected
Shanghai Ambiopharm Inc.Shanghai, China1 insp.
Henan Enokon Medical Instrument Co., Ltd.Xinxiang, China1 insp.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site)Nanjing, China1 insp.
Blue Sea Aerosol & Daily Care Co., LtdBaoding, China1 insp.
Zhejiang Lepu Pharmaceutical Co., Ltd.Taizhou, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Tiki Dixon7 shared
Jonathan W Chapman5 shared
Marc S Neubauer3 shared
Brian R Yaun3 shared
Zhong Li2 shared
Marvin D Jones2 shared
Philip F Istafanos2 shared
Ko U Min2 shared
Ileana Barreto-Pettit2 shared
Joey C West2 shared
Full investigator report
Get the verbatim findings behind Marcus A Ray's 299 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site